Outcomes of Titanium Mesh Cranioplasty in Pediatric Patients

Irene T Ma1, Melissa R Symon2, Ruth E Bristol3

  • 1Department of Surgery, Mayo Clinic Arizona, Phoenix, AZ.

Insights

Titanium mesh cranioplasty (TMC) effectively reconstructs pediatric cranial defects when autologous bone is limited. This study shows favorable outcomes with good symmetry and brain protection, despite minor complications.

Area of Science:

  • Pediatric Neurosurgery
  • Craniofacial Reconstruction
  • Biomaterials in Medicine

Background:

  • Cranial defects in children require reconstruction using various materials.
  • Limited literature exists on titanium mesh cranioplasty (TMC) outcomes in pediatric patients.
  • This study addresses the efficacy of TMC in pediatric calvarial reconstruction.

Purpose of the Study:

  • To evaluate the outcomes of titanium mesh cranioplasty (TMC) in pediatric patients with calvarial defects.
  • To assess the efficacy and safety of TMC in this specific population.
  • To provide data on TMC as an alternative to autologous bone grafts.

Main Methods:

  • Retrospective review of patients aged 18 years or younger who underwent cranioplasty between 1999 and 2014.
  • Focus on a cohort of 33 pediatric patients who underwent titanium mesh cranioplasty.
  • Data collected on etiologies, prior surgeries, mesh characteristics, complications, and follow-up.

Main Results:

  • Titanium mesh cranioplasty (TMC) was performed on 33 pediatric patients, with congenital syndromes and trauma as common etiologies.
  • Most patients had prior cranial surgeries; various mesh sizes were utilized.
  • Low complication rates were observed, with 2 patients experiencing perioperative issues and 2 late soft tissue problems. All patients achieved good cranial contour and brain protection.

Conclusions:

  • Titanium mesh cranioplasty (TMC) is a viable and effective option for pediatric cranial defects, especially when autologous bone is insufficient.
  • The interim outcomes are favorable, with minimal complications and no observed growth restriction.
  • Continued long-term follow-up is planned for these patients.
Abstract

Related Concept Videos